Review: Aldosterone-induced vasculopathy: a new reversible cause of cardiac death

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Free Full Text (Free PDF) Free
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Articles by Struthers, A. D
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Struthers, A. D


Social Bookmarking

	What's this?

Allan D Struthers

Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK, a.d.struthers@ dundee.ac.uk

Key Words: aldosterone • nitric oxide • fibrosis

References

MacFadyen RJ, Lee AFC, Morton JJ,Pringle SD, Struthers AD How often are AII and aldosterone concentrations raised during chronic ACI treatment in CCF. Heart 1999;82:57-61.[Abstract/Free Full Text]

Edmond M., Mock M., David KBV, Fisher LD, Holmes DR, Chaitman BR, Kaiser GC, Alderman E., Killip III T. and CASS Participants. Long term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry Circulation 1994;90:2645-57.

Zuanetti G., De Ferrari GM, Priori SG, Schwartz PJ Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res 1987;61(3):429-35.[Abstract/Free Full Text]

La Rovere MT, Bigger JT, Marcus FI, MortaraA, Sachwartz PJ for the ATRAMI Investigators.Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998;351:478-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Zuanetti G., Neilson JMM, Latini R., Santoro E., Maggioni AP, Ewing DJ on behalf of GISSI-2 investigators. Prognostic significance of heart rate variability in post myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Circulation 1996;94:432-6.[Abstract/Free Full Text]

Weber K., Brilla CG Pathological hypertrophy and cardiac interstitium: fibrosis and renin angiotensin aldosterone system. Circulation 1991;83:1849-65.[Abstract/Free Full Text]

Takeda Y., Miyamori I., Yoneda T. et al. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab 1996;81(8):2797-800.[Abstract/Free Full Text]

Ideka U., Kanbe T., Nakayama I., Kawahara Y., Yokoyama M., Shimada K. Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1. Eur J Pharmacol 1995;290:69-73.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Farquharson C., Struthers AD Spironolactone increases NO bioactivity, improves endothelial dysfunction and suppresses vascular AI/AII conversion in chronic heart failure. Circulation 2000;101:594-7.[Abstract/Free Full Text]

Duprez DA, de Buyzere ML, Reitzschel ER et al. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. Eur Heart J 1998;19:1371-6.[Abstract/Free Full Text]

Brown NJ, Kin KS, ChenYQ et al. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. J Clin Endocrinol Metab 2000;85:336-44.[Abstract/Free Full Text]

Rocha R., Chander PN, Zuckerman A., Stier CT Mineralocorticoid blockade reduces vascular injury in stroke prone hypertensive rats. Hypertension 1998;31[part 2]:451-8.[Abstract/Free Full Text]

Harada E.,Yoshimura M.,Yasul H. et al. Aldosterone induces ACE gene expression in cultured neonatal rat cardiocytes. Circulation 2001;104:137-9.[Abstract/Free Full Text]

Brilla CG, Matsubara LS, Weber KT Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronisin. J Mol Coll Cardiol 1993;25:563-75.[CrossRef]

Klappacher G., Franzen P., Haab D. et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 1995;75:913-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Diez J., Laviadfes C., Mayor G., Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Circulation 1995;91:1450-6.[Abstract/Free Full Text]

MacFadyen RJ, Barr CS, Struthers AD.Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 1997;35:30-4.[Abstract/Free Full Text]

Zannad F., Alla F., Dousset B. et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with CHF. Circulation 2000:102;2700-6.[Abstract/Free Full Text]

Pitt B., Zannad F., Remme WJ et al. The effect of spironolactone on mortality and morbidity in chronic heart failure. N Engl J Med 199;341:709-17.

Yee KM, Pringle SD, Struthers AD Circadian influence of aldosterone blockade on QT dispersion and heat rate variability in chronic heart failure. J Am Coll Cardiol 2001; 37:1800-7.[Abstract/Free Full Text]

Chowdhary S.,Townend JN Role of NO in the regulation of cardiovascular autonomic control. Clin Sci 1999;97:5-17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Spiker LE, Corti R., Binggeli C. et al. Baroreceptor dysfunction induced by NO synthase inhibition in humans. J Am Coll Cardiol 2000;36:213-8.[Abstract/Free Full Text]